Literature DB >> 30193849

The Zinc-Finger Protein ZCCHC3 Binds RNA and Facilitates Viral RNA Sensing and Activation of the RIG-I-like Receptors.

Huan Lian1, Ru Zang1, Jin Wei1, Wen Ye1, Ming-Ming Hu1, Yun-Da Chen2, Xia-Nan Zhang2, Yi Guo2, Cao-Qi Lei2, Qing Yang1, Wei-Wei Luo3, Shu Li4, Hong-Bing Shu5.   

Abstract

Recognition of viral RNA by the retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs) initiates innate antiviral immune response. How the binding of viral RNA to and activation of the RLRs are regulated remains enigmatic. In this study, we identified ZCCHC3 as a positive regulator of the RLRs including RIG-I and MDA5. ZCCHC3 deficiency markedly inhibited RNA virus-triggered induction of downstream antiviral genes, and ZCCHC3-deficient mice were more susceptible to RNA virus infection. ZCCHC3 was associated with RIG-I and MDA5 and functions in two distinct processes for regulation of RIG-I and MDA5 activities. ZCCHC3 bound to dsRNA and enhanced the binding of RIG-I and MDA5 to dsRNA. ZCCHC3 also recruited the E3 ubiquitin ligase TRIM25 to the RIG-I and MDA5 complexes to facilitate its K63-linked polyubiquitination and activation. Thus, ZCCHC3 is a co-receptor for RIG-I and MDA5, which is critical for RLR-mediated innate immune response to RNA virus.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  RIG-I-like receptors; RNA virus; ZCCHC3; co-receptor; innate antiviral response; polyubiquitination

Mesh:

Substances:

Year:  2018        PMID: 30193849     DOI: 10.1016/j.immuni.2018.08.014

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  35 in total

Review 1.  Distinct and Orchestrated Functions of RNA Sensors in Innate Immunity.

Authors:  GuanQun Liu; Michaela U Gack
Journal:  Immunity       Date:  2020-07-14       Impact factor: 31.745

2.  ZCCHC3 modulates TLR3-mediated signaling by promoting recruitment of TRIF to TLR3.

Authors:  Ru Zang; Huan Lian; Xuan Zhong; Qing Yang; Hong-Bing Shu
Journal:  J Mol Cell Biol       Date:  2020-05-18       Impact factor: 6.216

3.  Innate Immune Responses and Pulmonary Diseases.

Authors:  Tao Liu; Siqi Liu; Xiaobo Zhou
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  DAMP-driven metabolic adaptation.

Authors:  Kirsty Minton
Journal:  Nat Rev Immunol       Date:  2020-01       Impact factor: 53.106

5.  To TRIM or not to TRIM: the balance of host-virus interactions mediated by the ubiquitin system.

Authors:  Adam Hage; Ricardo Rajsbaum
Journal:  J Gen Virol       Date:  2019-12       Impact factor: 3.891

Review 6.  Genome-wide analysis of CCHC-type zinc finger (ZCCHC) proteins in yeast, Arabidopsis, and humans.

Authors:  Uri Aceituno-Valenzuela; Rosa Micol-Ponce; María Rosa Ponce
Journal:  Cell Mol Life Sci       Date:  2020-04-18       Impact factor: 9.261

7.  Foot-and-Mouth Disease Virus 3B Protein Interacts with Pattern Recognition Receptor RIG-I to Block RIG-I-Mediated Immune Signaling and Inhibit Host Antiviral Response.

Authors:  Xiangle Zhang; Zixiang Zhu; Congcong Wang; Fan Yang; Weijun Cao; Pengfei Li; Xiaoli Du; Furong Zhao; Xiangtao Liu; Haixue Zheng
Journal:  J Immunol       Date:  2020-09-11       Impact factor: 5.422

8.  VRK2 is involved in the innate antiviral response by promoting mitostress-induced mtDNA release.

Authors:  Wen-Rui He; Li-Bo Cao; Yu-Lin Yang; Duo Hua; Ming-Ming Hu; Hong-Bing Shu
Journal:  Cell Mol Immunol       Date:  2021-03-30       Impact factor: 11.530

Review 9.  The distinct roles of zinc finger CCHC-type (ZCCHC) superfamily proteins in the regulation of RNA metabolism.

Authors:  Yishu Wang; Yu Yu; Yidan Pang; Haojun Yu; Wenqi Zhang; Xian Zhao; Jianxiu Yu
Journal:  RNA Biol       Date:  2021-05-04       Impact factor: 4.652

10.  OTUD7B deubiquitinates SQSTM1/p62 and promotes IRF3 degradation to regulate antiviral immunity.

Authors:  Weihong Xie; Shuo Tian; Jiahui Yang; Sihui Cai; Shouheng Jin; Tao Zhou; Yaoxing Wu; Zhiyun Chen; Yanqin Ji; Jun Cui
Journal:  Autophagy       Date:  2022-01-31       Impact factor: 13.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.